FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental medicine and gastroenterology, and can be used for the entero- and pancreatoprotective action of non-steroid anti-inflammatory preparations in simulating the gastric ulcer and/or pancreatitis experimentally. To this effect, the simulation is preceded by administering courses of Ketanov, Celebrex or Ketonal. The preparations are administered parenterally. A dose for the first three days is 2.5-3.1 mg/kg. A dose for the following three days is 1.5-2.4 mg/kg. That is followed by four days in a dose of 0.5-1.4 mg/kg with the therapeutic course repeated 1.5-2 months later. For the first three days of the repeated course, a dose of the preparation makes 0.7-2.0 mg/kg. A dose for the following three days makes 2.1-2.6 mg/kg. And for the final four days, a dose of the preparation makes 2.7-3.1 mg/kg.
EFFECT: method provides the effective entero- and pancreatoprotective action of the non-steroid anti-inflammatory preparations in simulating the gastric ulcer and/or pancreatitis experimentally with reducing the toxicity of the exposure.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF STOMACH AND DUODENUM ULCEROUS DISEASE | 2003 |
|
RU2240119C1 |
METHOD OF GASTRIC ULCER PREVENTION | 2007 |
|
RU2328286C1 |
METHOD FOR MODELING NONSPECIFIC ULCERATIVE COLITIS CASES | 2006 |
|
RU2316055C1 |
METHOD OF EARLY DIAGNOSTICS OF GASTROESOPHAGEAL REFLUX DISEASE IN PATIENTS WITH OBESITY | 2008 |
|
RU2373866C1 |
METHOD FOR PROPHYLAXIS OF STOMACH AND DUODENUM ULCER DISEASES | 2003 |
|
RU2255731C1 |
METHOD OF PERITONITIS SIMULATION | 2008 |
|
RU2367029C1 |
METHOD FOR PREVENTION OF GASTROESOPHAGEAL REFLUX | 2008 |
|
RU2388066C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 2011 |
|
RU2473342C1 |
DIAGNOSTIC TECHNIQUE FOR CHOLAGENIC DIARRHOEA | 2011 |
|
RU2475182C1 |
METHOD OF TREATING DIVERTICULOSIS IN EXPERIMENT | 2011 |
|
RU2454730C1 |
Authors
Dates
2015-03-27—Published
2012-08-27—Filed